Show simple item record

dc.contributor.authorAmini, H
dc.contributor.authorRezaie, J
dc.contributor.authorVosoughi, A
dc.contributor.authorRahbarghazi, R
dc.contributor.authorNouri, M
dc.date.accessioned2018-08-26T04:55:36Z
dc.date.available2018-08-26T04:55:36Z
dc.date.issued2017
dc.identifier10.15171/jcvtr.2017.22
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/38375
dc.description.abstractStem cells (SCs) have special potency to differentiate into different types of cells, especially cardiomyocytes. In order to demonstrate the therapeutic applications of these cells, various investigations are recently being developed. Cardiac progenitor cells are endogenous cardiac SCs that found to express tyrosine kinase receptors, c-Kit and other stemness features in adult heart, contributing to the regeneration of cardiac tissue after injury. This lineage is able to efficiently trans-differentiate into different cell types such as cardiomyocytes, endothelial cells, and smooth muscle cells. Noticeably, several cardiac progenitor cells have been identified until yet. The therapeutic applications of cardiac SCs have been studied previously, which could introduce a novel therapeutic approach in the treatment of cardiac disorders. The current review enlightens the potency of cardiac progenitor cells features and differentiation capacity, with current applications in cardiovascular field.
dc.language.isoEnglish
dc.relation.ispartofJournal of cardiovascular and thoracic research
dc.titleCardiac progenitor cells application in cardiovascular disease.
dc.typearticle
dc.citation.volume9
dc.citation.issue3
dc.citation.spage127
dc.citation.epage132
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.15171/jcvtr.2017.22


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record